Abbott Laboratories agreed to pay $385 million to settle U.S. allegations related to poor manufacturing practices at two facilities, including one

South Bend's former mayor appears on NBC's Meet the Press. Plus, Abbott Laboratories agrees to pay over $384 million to settle federal allegations.

The case stems from a bacterial contamination at a Michigan plant from 2018 to 2022.

Unsanitary conditions at firm’s Michigan plant include roof leaks and inadequate cleaning procedures Read more at The Business Times.

The settlement resolves a case by the federal government related to allegations about false claims and is not a determination of liability on the part of the company.

Abbott Laboratories, the Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted to federal and state programs.

The Justice Department announced today that Abbott Laboratories has agreed to pay $384,999,040 to resolve False Claims Act allegations that,

Abbott will pay $385M to settle US and state claims over unsanitary infant formula manufacturing, resolving False Claims Act allegations and whistleblower award

Abbott Laboratories has agreed to pay more than $384 million to settle allegations that it supplied infant formula and nutritional products that were not manufactured in compliance with required health, safety and quality standards, the U.S. Department of Justice announced Monday.

Abbott Laboratories stock gained around 1 percent on September 14, 2026 after the company agreed to

The allegations stem from Abbott’s failure to manufacture certain powder infant formula and nutritional therapy products at its Sturgis, Michigan and Casa Grande, Arizona facilities in compliance with federal and state statutory, regulatory, and contractual requirements between January 1, 2018 and December 31, 2022.